Guardant Health, Inc.GHNASDAQ
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +33.87% | +30.16% | +20.76% | +30.95% | +38.50% |
| Gross Profit Growth | +36.96% | -47.41% | +24.76% | +43.95% | +46.69% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +4.51% | +4.43% | +1.77% | +1.36% | +1.43% |
| Weighted Average Shares Diluted Growth | +4.51% | +4.43% | +1.77% | +1.36% | +1.83% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | -0.38% | +24.18% | +36.50% | +29.58% | +30.66% |
| Inventory Growth | -6.15% | +14.75% | +22.65% | +25.49% | +25.16% |
| Asset Growth | -14.38% | -16.84% | -21.14% | -17.23% | -17.02% |
| Book Value per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Debt Growth | -1.39% | -1.31% | -3.05% | -0.52% | -0.97% |
| R&D Expense Growth | -6.97% | +4.10% | +5.63% | +5.23% | +3.04% |
| SG&A Expenses Growth | +39.86% | +34.12% | +27.03% | +38.84% | +22.88% |